Alpha Crest Capital Management LLC Insmed Inc Transaction History

Alpha Crest Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$17.07 - $25.71 $188,777 - $284,326	-11,059 Reduced 41.46%	15,618 $308,000
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $287,023 - $395,395	14,056 Added 111.37%	26,677 $627,000
Q4 2021 Feb 09, 2022	SELL	$25.89 - $33.45 $132,349 - $170,996	-5,112 Reduced 28.83%	12,621 $344,000
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $398,283 - $522,591	17,733 New	17,733 $488,000
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $361,675 - $466,210	-11,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$26.0 - $34.5 $299,000 - $396,750	11,500 New	11,500 $370,000

484

187M

2.15M

3.22M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.